Abstract

Cataracts, one of the leading causes of preventable blindness worldwide, refers to lens degradation that is characterized by clouding, with consequent blurry vision. As life expectancies improve, the number of people affected with cataracts is predicted to increase worldwide, especially in low-income nations with limited access to surgery. Although cataract surgery is considered safe, it is associated with some complications such as retinal detachment, warranting a search for cheap, pharmacological alternatives to the management of this ocular disease. The lens is richly endowed with a complex system of non-enzymatic and enzymatic antioxidants which scavenge reactive oxygen species to preserve lens proteins. Depletion and/or failure in this primary antioxidant defense system contributes to the damage observed in lenticular molecules and their repair mechanisms, ultimately causing cataracts. Several attempts have been made to counteract experimentally induced cataract using in vitro, ex vivo, and in vivo techniques. The majority of the anti-cataract compounds tested, including plant extracts and naturally-occurring compounds, lies in their antioxidant and/or free radical scavenging and/or anti-inflammatory propensity. In addition to providing an overview of the pathophysiology of cataracts, this review focuses on the role of various categories of natural and synthetic compounds on experimentally-induced cataracts.

Highlights

  • Cataracts, one of the leading causes of preventable blindness worldwide, refers to lens degradation that is characterized by clouding, with consequent blurry or hazy vision [1]

  • Reduced selenite induced cataract by 89% and reduced onset and progression of galactose induced cataract were observed with oral feeding of lycopene

  • With the projected increase in life expectancies, the number of people affected with cataract is predicted to increase worldwide

Read more

Summary

Introduction

One of the leading causes of preventable blindness worldwide, refers to lens degradation that is characterized by clouding, with consequent blurry or hazy vision [1]. As life expectancies improve throughout the globe, the number of people suffering from cataracts is predicted to increase worldwide [9], especially in low-income nations that lack easy access to cataract surgery, warranting a search for cheap, pharmacological alternatives to the management of this disease. Age-related cataracts can be further classified based upon the anatomical location of opacity within the lens into nuclear, cortical, and posterior subcapsular cataracts (Figure 1A–D) [11]. Posterior subcapsular cataracts, which affect the posterior cortex of the lens, are observed in relatively younger patients. This form of cataracts is associated with hyperopia and progresses faster than nuclear and cortical cataracts. SSSccceennee vviieewweedd bbyy nnoorrmmaall vviissiioonn ((aA))aannddaappeerrssoonnnwwiitiththhcccaaatttaaarrraaaccctttsss(((bBB)););;sssooouuurrrccceeedddffrfrrooommmNNNEEEIIIMMeeddiiaa LLMiibberdraairaryyL[[i11b33r]]a..ry [13]

Lens Anatomy and Physiology
Non-Enzymatic Antioxidants
Enzymatic Antioxidants
Molecular Mechanisms of Cataract Formation
Current Cataract Treatments
Potential Pharmacological Treatments for Cataracts
Antioxidants
Miscellaneous Drugs
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call